LFG
CLB icon

Larson Financial Group’s Core Laboratories CLB Stock Holding History

Larson Financial Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-54
Closed -$907 – 3799
2026
Q1 		$907 Buy
+54
New +$966 ﹤0.01% 3188
2025
Q3 		– Sell
-115
Closed -$1.32K – 3480
2025
Q2 		$1.32K Buy
+115
New +$1.36K ﹤0.01% 2549
2025
Q1 		– Sell
-60
Closed -$1.04K – 3090
2024
Q4 		$1.04K Buy
60
+10
+20% +$193 ﹤0.01% 2039
2024
Q3 		$927 Buy
+50
New +$1K ﹤0.01% 2007

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Larson Financial Group's CLB Position: Q2 2026 in Review

Larson Financial Group sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 54 shares — an estimated $907 sold.

Larson Financial Group first reported a position in CLB in Q3 2024 and held it in 4 quarters. The position peaked at $1.32K in Q2 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Larson Financial Group reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
  • Larson Financial Group sold 54 Core Laboratories shares in Q2 2026, an estimated $907.
  • Larson Financial Group first reported a position in Core Laboratories in Q3 2024 and held it in 4 quarters.
  • Larson Financial Group's Core Laboratories position peaked at $1.32K in Q2 2025.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.